Hematoporphyrin Derivative
- Name
- Hematoporphyrin Derivative
- Accession Number
- DBCAT001082
- Description
A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.
- Drugs
Drug Drug Description Porfimer sodium A hematoporphyrin derivative used to treat esophageal cancer, endobronchial cancer, and high grade dysplasia in Barrett's Esophagus. Dihematoporphyrin ether Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma). - Drugs & Drug Targets
Drug Target Type Porfimer sodium Low-density lipoprotein receptor target Porfimer sodium High affinity immunoglobulin gamma Fc receptor I target